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OBJECTIVES We sought to establish the distribution of the 10-year risk for coronary heart disease (CHD)
among U.S. adults.
BACKGROUND Risk assessment for CHD was developed to provide clinicians with a tool to estimate the
absolute risk of developing CHD. More recently, risk assessment is increasingly being
incorporated into guidelines for diagnostic testing and treatment. Yet, little is known about
the 10-year risk distribution for CHD among adults in the U.S. based on these risk
assessment tools.
METHODS We applied the risk prediction algorithm used by the National Cholesterol Education
Program Adult Treatment Panel III guidelines to data from 13,769 participants (representing
157,366,716 U.S. adults) age 20 to 79 years in the Third National Health and Nutrition
Examination Survey (1988 to 1994).
RESULTS Among participants without self-reported CHD (heart attack and angina pectoris), stroke,
peripheral vascular disease, and diabetes, 81.7% (140 million adults) had a 10-year risk for
CHD of 10%, 15.5% (23 million adults) of 10% to 20%, and 2.9% (4 million adults) of
20%. The proportion of the participants with a 10-year risk for CHD of 20% increased
with advancing age and was higher among men than among women but varied little with race
or ethnicity.
CONCLUSIONS Our results help to define the distribution of 10-year risk for CHD among U.S.
adults. (J Am Coll Cardiol 2004;43:1791–6) © 2004 by the American College of
Cardiology Foundationl
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aisk prediction for coronary heart disease (CHD) was
eveloped to help clinicians in estimating a patient’s abso-
ute risk for developing CHD. The earliest such effort was
one by Framingham Heart study investigators, and these
isk equations have been periodically updated (1,2). The
ational Cholesterol Education Program Expert Panel on
etection, Evaluation, and Treatment of High Blood Cho-
esterol in Adults (Adult Treatment Panel III) (NCEP/
TP III) has incorporated the use of risk assessment to
rovide clinicians with guidelines to treat dyslipidemia (3).
See page 1797
he NCEP/ATP III adopted a modification of the risk
rediction algorithm from the Framingham Heart study (2)
hat incorporates a patient’s age, total cholesterol concen-
ration, high-density lipoprotein cholesterol concentration,
moking status, and systolic blood pressure (BP) to estimate
person’s 10-year risk for developing CHD. Three levels of
isk were defined: 10%, 10% to 20%, and 20%. The
CEP/ATP III considered these levels of risk within a
roader framework of risk assessment that included estab-
From the Division of Adult and Community Health, National Center for Chronic
isease Prevention and Health Promotion, Centers for Disease Control and
revention, Atlanta, Georgia.
Manuscript received June 30, 2003; revised manuscript received November 24,w003, accepted November 25, 2003.ishing the presence of CHD and risk equivalents for CHD
s well as risk factor counting. Patients with CHD or a
HD risk equivalent are considered to be at very high risk
or sustaining an acute cardiovascular event.
More recently, risk assessment has been used to guide
linicians in performing diagnostic testing (4). In addition,
isk assessment may serve as a motivational tool. Thus, the
se of CHD risk assessment in developing guidelines may
e widening. Consequently, estimates of the numbers of
eople in each of the three categories of risk may be useful.
o determine the distribution of 10-year risk for CHD
mong adults in the U.S. as proposed by NCEP/ATP III,
e examined data from the Third National Health and
utrition Examination Survey (NHANES III).
ETHODS
etween 1988 and 1994, a representative sample of the
ivilian, non-institutionalized U.S. population was recruited
nto NHANES III using a multistage, stratified sampling
esign (5,6). After an interview in the home, participants
ere invited to attend a morning, afternoon, or evening
xamination. The survey received human subject approval
rom the Centers for Disease Control and Prevention.
The NCEP/ATP III risk prediction algorithm scoring
pproach has separate risk functions for men and for
omen. Total cholesterol concentration and high-density
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Distribution of CHD Risk May 19, 2004:1791–6ipoprotein cholesterol, after the precipitation of other
ipoproteins with a heparin-manganese chloride mixture,
ere measured using a Hitachi 704 Analyzer (Boehringer
annheim Diagnostics, Indianapolis, Indiana). Three BP
eadings were obtained in the mobile examination center.
he average of the second and third systolic BP and
iastolic BP readings were used in the analyses. Participants
ere asked whether they were currently using antihyperten-
ive medication. Participants were considered current smok-
rs if they reported smoking at least 100 cigarettes during
heir life and were currently smoking.
To define CHD, we used self-reported heart attack and
ngina pectoris derived from a series of questions. To define
HD risk equivalents, we used self-reported stroke and
iabetes; peripheral vascular disease was determined from a
eries of questions.
tatistical analyses. The NCEP/ATP III risk prediction
lgorithm was proposed for people age 20 to 79 years;
onsequently, only participants in this age range were
ncluded in the analyses. Analyses were limited to partici-
ants who attended the examination. We calculated esti-
ates using the sampling weights so that the estimates were
Abbreviations and Acronyms
BP  blood pressure
CHD  coronary heart disease
NCEP/ATP III  National Cholesterol Education
Program Expert Panel on Detection,
Evaluation, and Treatment of High
Blood Cholesterol in Adults (Adult
Treatment Panel III)
NHANES  National Health and Nutrition
Examination Survey
Table 1. Age-Adjusted Descriptive Informatio
Estimates for Coronary Heart Disease, Nation
1988 to 1994
M
n
M
Age (yrs)
Total cholesterol (mg/dl)
High-density lipoprotein cholesterol (mg/dl)
Systolic blood pressure (mm Hg)
Hypertension treatment, %
Current smoking, %
Risk factors for cardiovascular disease not
used to estimate risk*
Diastolic blood pressure (mm Hg)
Body mass index (kg/m2)
Waist circumference (cm)
Triglycerides (mg/dl)
Self-reported diabetes, %
C-reactive protein 3 mg/l, %
Self-reported use of cholesterol-lowering
medications, %*Sample sizes may vary.epresentative of the civilian, non-institutionalized U.S.
opulation. Age-adjustment was done using the direct
ethod and the age-distribution for the year 2000. To
ccount for the complex sampling design, all analyses were
onducted by using Software for the Statistical Analysis of
orrelated Data (SUDAAN, Research Triangle Institute,
esearch Triangle Park, North Carolina) to obtain proper
ariance estimates.
ESULTS
total of 13,769 participants (6,433 men and 7,336
omen) had complete information to calculate their 10-year
isk for CHD. An additional 289 participants without
omplete information reported having CHD or a CHD risk
quivalent (diabetes, peripheral vascular disease, or stroke).
ompared with women, men were younger, had lower
oncentrations of total cholesterol and high-density lipopro-
ein cholesterol, had higher systolic BP, were less likely to
se antihypertensive medication, and were more likely to
moke (Table 1).
Among participants without CHD (self-reported myo-
ardial infarction or angina pectoris) or a CHD risk equiv-
lent (diabetes, peripheral vascular disease, or stroke), 81.7%
ad a 10-year risk for CHD of 10%, 15.5% of 10% to
0%, and 2.9% of 20% (Table 2). The risk increased
trongly with advancing age, was greater among men than
omen, and did not differ much among the four racial or
thnic groups. We also calculated the risk distribution after
ssigning participants with CHD or a CHD risk equivalent
o the highest risk category (Table 3, Fig. 1). After adjusting
or age, 72.6% of participants had a 10-year risk for CHD
f 10%, 11.9% of 10% to 20%, and 15.6% of 20%.
Although the NCEP/ATP III report defined intermediate
Variables Included in the 10-Year Risk
alth and Nutrition Examination Survey III,
 6,433;
ighted
,960,017)
Women (n  7,336;
Weighted
n  81,406,699)
r % (SE) Mean or % (SE) p Value
.8 (0.4) 44.0 (0.4) 0.001
.6 (1.0) 205.6 (0.7) 0.037
.5 (0.4) 55.3 (0.4) 0.001
.7 (0.4) 116.9 (0.3) 0.001
.0 (0.6) 13.3 (0.5) 0.001
.1 (1.0) 25.3 (0.7) 0.001
.4 (0.3) 70.7 (0.3) 0.001
.7 (0.1) 26.6 (0.2) 0.457
.8 (0.2) 88.9 (0.4) 0.001
.6 (3.8) 125.0 (2.3) 0.001
.0 (0.3) 5.7 (0.5) 0.254
.2 (1.0) 31.1 (1.3) 0.001
.0 (0.3) 3.3 (0.3) 0.525n for
al He
en (n
We
 75
ean o
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11
32
76
26
95
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May 19, 2004:1791–6 Distribution of CHD Riskisk as 10% to 20%, a range of 6% to 20% has also been used.
herefore, we recalculated the estimates in Tables 2 and 3
sing the following categories: 6%, 6% to 20%, and 20%.
mong participants without CHD or a CHD risk equivalent,
2.8% (men: 55.0%; women: 88.4%) had a 10-year risk of
6%, 24.4% (men: 39.7%; women: 10.8%) had a risk of 6% to
0%, and 2.9% (men: 5.3%; women: 0.9%) had a risk of
20%. When participants with CHD or a CHD risk equiv-
lent were assigned to the highest risk category, 65.4% (men:
1.7%; women: 77.8%) had a 10-year risk of 6%, 19.1%
men: 31.0%; women: 8.1%) had a risk of 6% to 20%, and
5.6% (men: 17.3%; women: 14.1%) had a risk of 20%.
able 2. Age-Specific and Age-Adjusted Distribution Risk for C
ithout Self-Reported Coronary Heart Disease or a Coronary H
xamination Survey III, 1988 to 1994
n Weighted, n <10%
otal 11,611 138,463,213 81
ender
Men 5,481 67,159,469 66
Women 6,130 71,303,744 94
ge (yrs)
Total
20–29 2,951 34,410,851 99
30–39 2,778 36,429,134 95
40–49 2,022 27,827,102 89
50–59 1,345 17,152,023 70
60–69 1,486 13,884,733 55
70–79 1,029 8,759,370 34
Men
20–29 1,388 17,394,942 99
30–39 1,256 18,193,189 91
40–49 988 13,843,244 80
50–59 614 8,120,105 40
60–69 767 6,101,047 8
70–79 468 3,506,943 2
Women
20–29 1,563 17,015,909 100
30–39 1,522 18,235,945 99
40–49 1,034 13,983,858 99
50–59 731 9,031,919 98
60–69 719 7,783,687 91
70–79 561 5,252,426 55
ace or ethnicity
Total
White 4,573 106,562,092 81
African American 3,290 13,978,761 80
Mexican American 3,249 6,937,452 80
Other 499 10,984,907 83
Men
White 2,077 51,612,956 65
African American 1,527 6,480,578 66
Mexican American 1,658 3,727,827 67
Other 219 5,338,108 69
Women
White 2,496 54,949,136 95
African American 1,763 7,498,183 92
Mexican American 1,591 3,209,625 94
Other 280 5,646,799 94
Self-reported myocardial infarction, angina pectoris, history of stroke, peripheral vas
or Cochran-Mantel-Haenszel chi-square test for age-adjusted data; ‡estimate mayBy applying the age-specific proportions of participants in fach risk stratum to the year 2000 U.S. population age 20 to
9 years without CHD or a CHD equivalent, as we defined
t, we estimated that about 140 million people had a 10-year
isk for CHD of 10%, 23 million of 10% to 20%, and 4
illion of 20%. In addition, another 24 million people
ad CHD or a CHD equivalent.
Among participants who had a CHD risk equivalent or
20% 10-year risk for developing CHD or sustaining a
ardiovascular event, 59.2% had self-reported diabetes,
4.8% had a stroke, 5.3% had peripheral vascular disease,
nd 36.1% had a 10-year risk for CHD 20% (Table 4).
hen the analysis was limited to participants who had
ary Heart Disease Among United States Adults Age 20 Years
Disease Equivalent,* National Health and Nutrition
10-Year Risk for Coronary Heart Disease
p†SE) 10% to 20%, % (SE) >20%, % (SE)
5) 15.5 (0.5) 2.9 (0.2) —
0.001
6) 28.7 (0.8) 5.3 (0.4)
3) 4.3 (0.3) 0.9 (0.1)
0.001
1) 0.1 (0.1)‡ 0.0 (0.0)
8) 3.7 (0.8) 0.6 (0.2)‡
8) 8.5 (0.8) 1.8 (0.5)
7) 25.3 (1.7) 3.8 (0.6)
2) 40.1 (1.3) 5.0 (0.6)
6) 51.5 (1.5) 14.0 (1.4)
0.001
2) 0.2 (0.2)‡ 0.0 (0.0)
5) 7.4 (1.6) 1.2 (0.4)
7) 16.2 (1.6) 3.6 (0.9)
4) 52.0 (2.6) 7.4 (1.3)
4) 80.8 (1.7) 10.8 (1.4)
7) 75.5 (2.4) 22.0 (2.5)
0.001
0) 0.0 (0.0) 0.0 (0.0)
1) 0.1 (0.1)† 0.0 (0.0)
4) 0.8 (0.4)† 0.1 (0.0)‡
6) 1.4 (0.5)† 0.4 (0.2)‡
2) 8.2 (1.2) 0.3 (0.2)‡
5) 35.5 (2.1) 8.6 (1.5)
0.289
5) 15.6 (0.5) 2.8 (0.3)
6) 16.1 (0.6) 3.5 (0.3)
8) 16.7 (0.7) 2.8 (0.3)
4) 14.0 (2.0) 2.9 (1.2)‡
0.275
8) 29.2 (0.8) 5.2 (0.4)
3) 28.2 (1.2) 5.8 (0.6)
1) 28.2 (1.2) 4.8 (0.5)
4) 24.0 (3.6) 6.3 (2.7)‡
0.002
3) 4.1 (0.3) 0.8 (0.1)
6) 5.8 (0.6) 1.5 (0.3)
7) 5.1 (0.7) 0.6 (0.3)‡
1) 5.2 (1.1) 0.3 (0.2)‡
isease, or diabetes mellitus; †p value is for chi-square test for unadjusted results and
table and should be interpreted cautiously.oron
eart
, % (
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Distribution of CHD Risk May 19, 2004:1791–6f participants had diabetes (self-report or 126 mg/dl),
2.2% had stroke, 4.6% had peripheral vascular disease, and
2.8% had a 10-year risk for CHD 20%.
ISCUSSION
he results from our analyses may help to better define the
ercentages and numbers of U.S. adults at three levels of
isk for CHD during a 10-year interval. Such information
ay be helpful to those developing diagnostic and treatment
uidelines for topics related to CHD. These findings may
lso help in estimating costs associated with such guidelines.
n addition, this information may hold promise for surveil-
ance purposes. Health care organizations use prediction
odels for various purposes including identifying members
t increased risk for incurring high costs and planning care
elivery (7,8). Although risk prediction using information
rom their own memberships is of greater practical use to
hose organizations, results such as ours may still be useful
or making comparisons with national data.
Several issues may have affected the accuracy of our
umbers. The definitions used in this study for CHD and
HD equivalent were based on self-reported data provided
y the participants. Such data may underestimate the true
revalence of these conditions. If we had been able to detect
hese conditions more accurately, our estimates of the
ercentage of participants in each risk stratum would likely
ave been lower. For example, if the prevalence of CHD or
HD equivalent were twice as large as our estimates, about
23 million people would have had a 10-year risk for CHD
able 3. Age-Specific and Age-Adjusted Distribution of Risk for
ncluding People With Self-Reported Coronary Heart Disease or
ategory, National Health and Nutrition Examination Survey III
n Weighted, n <10%
otal 14,058 159,308,285 72.
ender
Men 6,563 76,748,866 61.
Women 7,495 82,559,418 82.
ace or ethnicity
Total
White 5,487 122,096,537 73.
African American 4,020 16,761,822 68.
Mexican American 3,970 8,039,538 68.
Other 581 12,410,388 73.
Men
White 2,541 59,255,039 60.
African American 1,814 7,473,158 59.
Mexican American 1,965 4,179,034 60.
Other 243 5,841,635 65.
Women
White 2,946 62,841,498 84.
African American 2,206 9,288,664 74.
Mexican American 2,005 3,860,504 75.
Other 338 6,568,753 80.
Self-reported myocardial infarction, angina pectoris, history of stroke, peripheral vas
or Cochran-Mantel-Haenszel chi-square test for age-adjusted data.f 10%, 16.5 million of 10% to 20%, and 3 million of20%. Smoking was self-reported, which likely underesti-
ated the true prevalence of smoking. This, in turn, may
ave resulted in an underestimate of the percentage of
articipants who had a 10-year risk for CHD of 10% to 20%
r 20%.
The Framingham coronary disease prediction algorithm
hat formed the basis for the NCEP/ATP III risk scoring
lgorithm used age, low-density lipoprotein cholesterol
oncentration, total cholesterol concentration, high-density
ipoprotein cholesterol concentration, BP, diabetes, and
moking status and was developed for people age 30 to 74
ears (2). Several changes to this algorithm were adopted by
CEP/ATP III. The age range was broadened to include
eople age 20 to 79 years. Low-density lipoprotein choles-
erol was not included. Different high-density lipoprotein
holesterol categories were used. Points assigned for BP
epended on treatment status, which was not considered by
he Framingham algorithm. Finally, points assigned for
moking status were dependent on age, whereas in Fra-
ingham age was not a factor. Because diabetes was
onsidered a risk equivalent by the NCEP/ATP III, it was
ot incorporated in the risk-scoring algorithm.
The NCEP/ATP III describes two approaches to risk
ssessment in persons without CHD or CHD risk equiva-
ents. The principal approach consists of first counting the
umber of risk factors using five factors: cigarette smoking,
ypertension, low-, high-density lipoprotein cholesterol
oncentration, family history of premature CHD, and age.
or people with 2 risk factors, NCEP/ATP III recom-
ends calculating the 10-year risk for CHD. The second
onary Heart Disease Among U.S. Adults Age 20 Years After
onary Heart Disease Risk Equivalents* in the Highest Risk
8 to 1994
10-Year Risk for Coronary Heart Disease
SE) 10% to 20%, % (SE) >20%, % (SE) p†
) 11.9 (0.4) 15.6 (0.6)
0.001
) 21.7 (0.7) 17.3 (0.6)
) 3.1 (0.2) 14.1 (0.8)
0.001
) 12.1 (0.4) 14.6 (0.7)
) 10.8 (0.6) 21.2 (0.8)
) 11.3 (0.5) 20.3 (0.6)
) 11.0 (1.3) 15.2 (1.3)
0.044
) 22.1 (0.8) 17.0 (0.7)
) 20.5 (1.0) 19.7 (0.9)
) 20.5 (1.0) 19.2 (0.7)
) 19.0 (2.7) 15.1 (2.5)
0.001
) 3.0 (0.2) 12.5 (1.0)
) 3.4 (0.4) 22.4 (1.3)
) 2.8 (0.4) 21.5 (0.8)
) 4.0 (0.7) 15.2 (1.8)
isease, or diabetes mellitus; †p value is for chi-square test for unadjusted results andCor
Cor
, 198
, % (
6 (0.7
0 (0.7
8 (0.8
3 (0.8
0 (0.6
4 (0.8
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CHD  coronary heart disease.
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May 19, 2004:1791–6 Distribution of CHD Riskpproach consists of first calculating the 10-year risk score
or CHD and, in people with a 10-year risk 10%, count
he number of risk factors. People with CHD or a CHD
isk equivalent are automatically considered to be at highest
isk under either approach. We followed the latter approach
ut did not count risk factors in participants with a 10-year
isk for CHD of 10%, primarily because of difficulty in
efining a family history of CHD as described by NCEP/
TP III.
The NHANES III provided the most recent national
ata to estimate risk, but newer data for some of the risk
actors needed for risk estimation is becoming available. The
.S. population has grown older. Cholesterol concentra-
ions have changed little from the 1988 to 1994 period to
he 1999 to 2000 period (9). National trends in high-density
ipoprotein cholesterol concentration remain unknown. A
ignificant increase in hypertension has occurred during this
ime, and the percentage of people with hypertension who
re using antihypertensive medications has increased (10).
igarette smoking decreased during the early part of the
990s before leveling off (11). Thus, the net effect of the
rends of risk factors on the population risk distribution of
ardiovascular disease is difficult to predict.
The use of risk categories instead of equations may yield
ess accurate estimates of absolute risk. Newer analytical
echniques may provide more accurate risk estimates in the
uture (12). In addition, most risk equations and the
CEP/ATP III risk prediction algorithm are based on a
imited set of variables. Factors—such as obesity, physical
ctivity, diabetes, triglyceride concentration, family history
f CHD, and so on—are not included in the NCEP/ATP
II risk calculation. Furthermore, emerging risk factors for
HD, such as C-reactive protein concentration, may im-
rove risk prediction. In the future, risk algorithms may be
efined and incorporate additional risk factors.
The generalizability of the NCEP/ATP III risk prediction
lgorithm has not been tested directly. However, the Framing-
am risk equation that was used to develop the algorithm had
een tested in several U.S. as well as European populations
13–20). In the U.S., the Framingham risk prediction algo-
ithm appears to predict risk reasonably well among various
opulations but not Native Americans (17).
ong 3,026* U.S. Adults Age 20 Years
nd Nutrition Examination Survey III, 1988
Total Men Women
45.3 (1.1) 42.9 (1.8) 47.9 (1.6)
10.9 (0.9) 10.5 (1.5) 11.3 (1.3)
3.8 (0.6) 3.6 (0.7) 4.1 (0.9)
g those 58.0 (1.4) 52.3 (1.9) 63.4 (1.9)
CHD or 11.8 (1.0) 19.3 (1.5) 4.1 (0.6)
lusive. *Represents 25,785,513 U.S. adults.igure 1. Age-specific distribution of risk for coronary heart disease
CHD) among U.S. adults age 20 years after including people with
elf-reported CHD or CHD risk equivalents (history of diabetes mellitus,
eripheral vascular disease, or stroke) in the highest risk category, National
ealth and Nutrition Examination Survey III, 1988 to 1994. Hatched
ars  20%; solid bars  10% to 20%; open bars  10%.Table 4. Distribution of CHD Risk Equivalents Am
With Any Such Risk Equivalent, National Health a
to 1994
Self-reported myocardial infarction and angina pectoris
Stroke
Peripheral vascular disease
Diabetes (self-report or plasma glucose 126 mg/dl amon
fasting 8 h)
10-year risk for CHD 20% among participants without
a CHD risk equivalent
Values represent percentage (SE). Conditions are not mutually exc
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Distribution of CHD Risk May 19, 2004:1791–6Few studies have provided estimates of the distribution of
isk for CHD in populations. In a British study of 126
ypertensive men, 50% had a risk of2% per year, and 28%
ad a risk of 3% per year based on the risk function of the
rospective Cardiovascular Mu¨nster study (21). In a study
f 691 British participants age 30 to 70 years recruited from
rimary care practices, 8.5% had a 10-year projected risk for
HD of 30%, and 42.1% had a projected risk of 15%
22). In a study of 1,102 British men and women, the
0-year risk for CHD of 30% was 6.5% among men and
.8% among women (19). The 10-year risk for 15% to 29%
as 34.8% for men and 19.4% for women. In an analysis of
ata from the Prospective Cardiovascular Mu¨nster study,
.9% to 8.4% of men age 35 to 65 years had a 10-year risk
f 20% (12). The variability of estimates occurred because
f the different approaches used for calculating risk. Our
nalysis of NHANES III data of participants age 20 to 79
ears showed that 5.3% of men and 0.9% of women had a
0-year risk for CHD of 20%, and 28.7% of men and
.3% of women had a 10-year risk for CHD of 10% to 20%.
he large difference between the sexes in our analyses was
onsistent with findings by Rabindranath et al. (19).
In conclusion, we have provided estimates of the distri-
ution of 10-year CHD risk among U.S. adults and have
stimated the numbers of U.S. adults in each risk stratum.
he risk distribution differed significantly among age
roups and among men and women. Relatively little racial
r ethnic variation was found. As the various risk stratifi-
ation schemes evolve, new estimates will be needed. Hope-
ully, our estimates will provide useful information to
esearchers and clinicians who develop guidelines for diag-
ostic testing and treatment as well as policy makers.
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